Business
Chimeric opens CHM CDH17 Phase 1/2 trial
Chimeric opens CHM CDH17 Phase 1/2 trial

About this update from Chimeric Therapeutics Limited
Chimeric Therapeutics Ltd has released a press release. View Attachment
View stock analysis, news, and events for Chimeric Therapeutics Limited